• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞病如何影响全膝关节置换术患者的围手术期结局?一项基于大型全国住院患者样本的研究。

How does sickle cell disease affect the peri-operative outcome in patients undergoing total knee arthroplasty? A large-scale, National Inpatient Sample-based study.

机构信息

Department of Orthopedics, University of Calgary, Calgary, AB, Canada.

Resident-Henry Ford Hospital, Jackson, MI, USA.

出版信息

Arch Orthop Trauma Surg. 2023 Aug;143(8):5261-5268. doi: 10.1007/s00402-022-04762-1. Epub 2023 Jan 2.

DOI:10.1007/s00402-022-04762-1
PMID:36592196
Abstract

INTRODUCTION

In view of the vaso-occlusive pathophysiology affecting osseous micro-circulation, sickle cell disease (SCD) is well known to present with diverse skeletal and arthritic manifestations. With prolonged life-expectancy over the past decades, there has been a progressive increase in the proportion of SCD patients requiring joint reconstructions. Owing to the paucity of evidence in the literature, the post-operative complication rates and outcome in these patients following total knee arthroplasty (TKA) are still largely unknown.

METHODS

Based on the National Inpatient Sample (NIS) database (using ICD-10 CMP code), patients who underwent TKA between 2016 and 2019 were identified. The cohort were classified into two groups: A-those with SCD; and B-those without. The data on patients' demographics, co-morbidities, details regarding hospital stay including expenditure incurred, and complications were analyzed and compared.

RESULTS

Overall, 558,361 patients underwent unilateral, primary TKA; among whom, 493 (0.1%) were known cases of SCD (group A). Group A included a significantly greater proportion of younger (60.14 ± 10.87 vs 66.72 ± 9.50 years; p < 0.001), male (77.3 vs 61.5%; p < 0.001); and African-American (88.2 vs 8.3%B; p < 0.001) patients, in comparison with group B. Group A patients were also at a significantly higher risk for longer duration of peri-operative hospital stay (p < 0.001), greater health-care costs incurred (p < 0.001), and greater need for alternative step-down health-care facilities (p < 0.001) following discharge. Among the SCD patients, 24.7%, 20.9% and 24.9% developed acute chest syndrome, pain crisis and splenic sequestration crisis, respectively during the peri-operative period. Group A patients had a statistically greater incidence of acute renal failure (ARF; p = 0.014), need for blood transfusion (p < 0.001) and deep vein thrombosis (DVT; p = 0.03) during the early admission period.

CONCLUSION

The presence of SCD substantially lengthens the duration of hospital stay and enhances health care-associated expenditure in patients undergoing TKA. SCD patients are at significantly higher risk for systemic complications including acute chest syndrome, pain crisis, splenic sequestration crisis, acute renal failure, higher need for blood transfusions and deep venous thrombosis during the initial peri-operative period following TKA.

摘要

简介

鉴于影响骨骼微循环的血管阻塞性病理生理学,镰状细胞病(SCD)众所周知会表现出多种骨骼和关节表现。在过去几十年中,预期寿命延长,需要进行关节重建的 SCD 患者比例逐渐增加。由于文献中证据不足,这些患者在接受全膝关节置换术(TKA)后的术后并发症发生率和结果在很大程度上仍然未知。

方法

基于国家住院患者样本(NIS)数据库(使用 ICD-10 CMP 代码),确定了 2016 年至 2019 年间接受 TKA 的患者。将队列分为两组:A-患有 SCD 的患者;B-无 SCD 的患者。分析和比较了患者人口统计学、合并症、住院时间(包括所产生的费用)以及并发症等方面的数据。

结果

总体而言,558361 例患者接受了单侧初次 TKA;其中,493 例(0.1%)为已知的 SCD 病例(A 组)。A 组包括比例显著更高的年轻患者(60.14±10.87 岁 vs 66.72±9.50 岁;p<0.001)、男性(77.3% vs 61.5%;p<0.001)和非裔美国人(88.2% vs 8.3%B;p<0.001)患者。与 B 组相比。与 B 组相比,A 组患者的围手术期住院时间更长(p<0.001),医疗费用更高(p<0.001),出院后更需要替代的降阶梯医疗设施(p<0.001)。在 SCD 患者中,分别有 24.7%、20.9%和 24.9%在围手术期发生急性胸部综合征、疼痛危象和脾隔离危象。A 组患者发生急性肾衰竭(ARF;p=0.014)、需要输血(p<0.001)和深静脉血栓形成(DVT;p=0.03)的发生率显著更高。

结论

SCD 的存在显著延长了 TKA 患者的住院时间,并增加了与医疗保健相关的支出。SCD 患者在接受 TKA 后的初始围手术期内,发生急性胸部综合征、疼痛危象、脾隔离危象、急性肾衰竭、更需要输血和深静脉血栓形成等全身并发症的风险显著更高。

相似文献

1
How does sickle cell disease affect the peri-operative outcome in patients undergoing total knee arthroplasty? A large-scale, National Inpatient Sample-based study.镰状细胞病如何影响全膝关节置换术患者的围手术期结局?一项基于大型全国住院患者样本的研究。
Arch Orthop Trauma Surg. 2023 Aug;143(8):5261-5268. doi: 10.1007/s00402-022-04762-1. Epub 2023 Jan 2.
2
Does systemic lupus erythematosus impact the peri-operative complication rates following primary total knee arthroplasty? A national inpatient sample-based large-scale study.系统性红斑狼疮是否会影响初次全膝关节置换术后的围手术期并发症发生率?一项基于全国住院患者样本的大规模研究。
Arch Orthop Trauma Surg. 2023 Jun;143(6):3291-3298. doi: 10.1007/s00402-022-04581-4. Epub 2022 Aug 17.
3
How does systemic lupus erythematosus impact the peri-operative complication rates in primary hip arthroplasty? A national inpatient sample-based study.系统性红斑狼疮如何影响初次髋关节置换术的围手术期并发症发生率?一项基于全国住院患者样本的研究。
Arch Orthop Trauma Surg. 2023 Apr;143(4):2209-2216. doi: 10.1007/s00402-022-04475-5. Epub 2022 May 28.
4
Preoperative blood transfusions for sickle cell disease.镰状细胞病的术前输血
Cochrane Database Syst Rev. 2020 Jul 2;7(7):CD003149. doi: 10.1002/14651858.CD003149.pub4.
5
Does sickle cell disease increase risk of adverse outcomes following total hip and knee arthroplasty? A nationwide database study.镰状细胞病会增加全髋关节和膝关节置换术后不良结局的风险吗?一项全国性数据库研究。
J Arthroplasty. 2015 Apr;30(4):547-51. doi: 10.1016/j.arth.2014.10.035. Epub 2014 Nov 11.
6
Incidence and Risk Factors of In-Hospital Prosthesis-Related Complications Following Total Knee Arthroplasty: A Retrospective Nationwide Inpatient Sample Database Study.全膝关节置换术后住院期间假体相关并发症的发生率及危险因素:一项回顾性全国住院患者样本数据库研究。
Orthop Surg. 2021 Jul;13(5):1579-1586. doi: 10.1111/os.13008. Epub 2021 Jun 9.
7
Patient disposition after discharge following primary total hip arthroplasty: home versus skilled nursing facility-a study based on national inpatient sample database.初次全髋关节置换术后出院患者去向:家庭与专业护理机构——基于国家住院患者样本数据库的研究。
Arch Orthop Trauma Surg. 2024 Feb;144(2):937-945. doi: 10.1007/s00402-023-05081-9. Epub 2023 Oct 11.
8
Total knee arthroplasty in schizophrenia patients: early complications and cost in a propensity-matched national database study.精神分裂症患者全膝关节置换术:倾向匹配全国数据库研究中的早期并发症和成本。
Arch Orthop Trauma Surg. 2024 Aug;144(8):3583-3590. doi: 10.1007/s00402-024-05436-w. Epub 2024 Jul 5.
9
Ankylosing spondylitis substantially increases health-care costs and length of hospital stay following total hip arthroplasty - National in-patient database study.强直性脊柱炎显著增加全髋关节置换术后的医疗费用和住院时间——全国住院患者数据库研究
J Clin Orthop Trauma. 2023 Apr 7;39:102151. doi: 10.1016/j.jcot.2023.102151. eCollection 2023 Apr.
10
Impact of Bariatric Surgery on Outcomes of Patients with Sickle Cell Disease: a Nationwide Inpatient Sample Analysis, 2004-2014.减重手术对镰状细胞病患者结局的影响:2004-2014 年全国住院患者样本分析。
Obes Surg. 2019 Jun;29(6):1789-1796. doi: 10.1007/s11695-019-03780-0.

引用本文的文献

1
Sickle Cell Disease Has No Impact on 10-Year Cumulative Incidence and Indications for Revision Lumbar Fusion.镰状细胞病对10年累积发病率及翻修性腰椎融合术的指征无影响。
Global Spine J. 2025 Apr;15(3):1592-1597. doi: 10.1177/21925682241253154. Epub 2024 May 9.
2
What are the predisposing factors for periprosthetic fractures following total hip arthroplasty? - a National Inpatient Sample-based study.全髋关节置换术后假体周围骨折的诱发因素有哪些?-一项基于国家住院患者样本的研究。
Arch Orthop Trauma Surg. 2024 Jun;144(6):2803-2810. doi: 10.1007/s00402-024-05343-0. Epub 2024 Apr 25.

本文引用的文献

1
Total hip arthroplasty for sickle cell osteonecrosis: guidelines for perioperative management.镰状细胞性骨坏死的全髋关节置换术:围手术期管理指南
EFORT Open Rev. 2020 Oct 26;5(10):641-651. doi: 10.1302/2058-5241.5.190073. eCollection 2020 Oct.
2
Total hip arthroplasty in sickle cell disease: a systematic review.镰状细胞病中的全髋关节置换术:一项系统评价
EFORT Open Rev. 2020 Mar 2;5(3):180-188. doi: 10.1302/2058-5241.5.190038. eCollection 2020 Mar.
3
Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management.
镰状细胞病中的骨坏死:风险因素、诊断和治疗的最新进展。
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):351-358. doi: 10.1182/hematology.2019000038.
4
Does Hemophilia Increase Risk of Adverse Outcomes Following Total Hip and Knee Arthroplasty? A Propensity Score-Matched Analysis of a Nationwide, Population-Based Study.血友病是否会增加全髋关节和膝关节置换术后不良结局的风险?一项基于全国人群的倾向评分匹配分析。
J Arthroplasty. 2019 Oct;34(10):2329-2336.e1. doi: 10.1016/j.arth.2019.05.062. Epub 2019 Jun 22.
5
Sickle cell disease and readmissions rates after lower extremity arthroplasty: a multistate analysis 2007-2014.镰状细胞病与下肢关节置换术后再入院率:2007-2014 年多州分析
J Comp Eff Res. 2019 Apr;8(6):403-422. doi: 10.2217/cer-2018-0098. Epub 2019 Mar 20.
6
Identifying high-cost episodes in lower extremity joint replacement.确定下肢关节置换术的高费用病例。
Health Serv Res. 2019 Feb;54(1):117-127. doi: 10.1111/1475-6773.13078. Epub 2018 Nov 5.
7
Risk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysis.全髋关节置换术和全膝关节置换术后静脉血栓栓塞的危险因素:一项荟萃分析。
Arch Orthop Trauma Surg. 2015 Jun;135(6):759-72. doi: 10.1007/s00402-015-2208-8. Epub 2015 Apr 9.
8
Does sickle cell disease increase risk of adverse outcomes following total hip and knee arthroplasty? A nationwide database study.镰状细胞病会增加全髋关节和膝关节置换术后不良结局的风险吗?一项全国性数据库研究。
J Arthroplasty. 2015 Apr;30(4):547-51. doi: 10.1016/j.arth.2014.10.035. Epub 2014 Nov 11.
9
Sickle cell disease, vasculopathy, and therapeutics.镰状细胞病、血管病变和治疗学。
Annu Rev Med. 2013;64:451-66. doi: 10.1146/annurev-med-120611-143127. Epub 2012 Nov 26.
10
Osteoarticular involvement in sickle cell disease.镰状细胞病的骨关节受累情况。
Rev Bras Hematol Hemoter. 2012;34(2):156-64. doi: 10.5581/1516-8484.20120036.